Neurotrack

Redwood City, United States Founded: 2012 • Age: 14 yrs
Neurological disorders are diagnosed using eye-tracking assessment tools.
Request Access

About Neurotrack

Neurotrack is a company based in Redwood City (United States) founded in 2012 by Elli Kaplan.. Neurotrack has raised $57.81 million across 12 funding rounds from investors including Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine. Neurotrack offers products and services including Cognitive Assessment and Cognitive Screening Platform. Neurotrack operates in a competitive market with competitors including Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others.

  • Headquarter Redwood City, United States
  • Founders Elli Kaplan
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Neurotrack Technologies, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Artificial Intelligence & Machine Learning
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $57.81 M (USD)

    in 12 rounds

  • Latest Funding Round
    $10 M (USD), Series C

    Nov 02, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Neurotrack

Neurotrack offers a comprehensive portfolio of products and services, including Cognitive Assessment and Cognitive Screening Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

3-minute test for detecting cognitive impairment and dementia.

Platform integrating with EHR for early diagnosis of neurodegenerative conditions.

People of Neurotrack
Headcount 50-200
Employee Profiles 13
Board Members and Advisors 3
Employee Profiles
People
Emily Lapkin
Head Of Marketing And Communications
People
Teresa Dean
Director Of Product
People
Elli Kaplan
Co-Founder and CEO
People
Katherine Wallace
Head of Compliance

Unlock access to complete

Board Members and Advisors
people
Elizabeth Buffalo
Scientific Co-Founder
people
Stewart Zola
Scientific Co-Founder
people
Cecilia Manzanares
Scientific Co-Founder

Unlock access to complete

Funding Insights of Neurotrack

Neurotrack has successfully raised a total of $57.81M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 12
  • Last Round Series C — $10.0M
  • First Round

    (17 Aug 2012)

  • Investors Count 15
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2022 Amount Series C - Neurotrack Valuation

investors

Jun, 2019 Amount Series C - Neurotrack Valuation Khosla Ventures
Apr, 2019 Amount Grant - Neurotrack Valuation

investors

NIA
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Neurotrack

Neurotrack has secured backing from 15 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Khosla Ventures, Social Capital and Johnson & Johnson Innovative Medicine. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Early-stage startups are funded by this venture capital firm.
Founded Year Domain Location
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada
Founded Year Domain Location
AME Cloud Ventures is focused on investing in data-driven technology companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Neurotrack

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Neurotrack

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Neurotrack Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Neurotrack

Neurotrack operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
domain founded_year HQ Location
Eye-tracking solutions for vision assessment and treatment are provided.
domain founded_year HQ Location
Micro-navigation systems for stroke surgery are developed.
domain founded_year HQ Location
Eye-tracking devices are developed for neurodegenerative disease monitoring.
domain founded_year HQ Location
Non-invasive eye scanner for early Alzheimer’s detection is developed.
domain founded_year HQ Location
Eye-tracking technology is utilized to detect traumatic brain injuries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Neurotrack

Frequently Asked Questions about Neurotrack

When was Neurotrack founded?

Neurotrack was founded in 2012.

Where is Neurotrack located?

Neurotrack is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Who is the current CEO of Neurotrack?

Elli Kaplan is the current CEO of Neurotrack. They have also founded this company.

Is Neurotrack a funded company?

Neurotrack is a funded company, having raised a total of $57.81M across 12 funding rounds to date. The company's 1st funding round was a Grant of $3.3M, raised on Aug 17, 2012.

What does Neurotrack do?

The company was founded in 2012 in Redwood City, United States, within the healthcare technology sector. Clinical assessment tools are provided for diagnosing neurological disorders, incorporating the Imprint Memory Assessment. This proprietary method employs computer vision algorithms and eye-tracking technology to evaluate behavioral biomarkers during cognitive and visual tests. Partnerships with pharmaceutical firms and researchers are maintained to facilitate clinical trial recruitment, assess drug efficacy, and advance drug development processes.

Who are the top competitors of Neurotrack?

Neurotrack's top competitors include NovaSight, RetiSpec and Tobii Dynavox.

What products or services does Neurotrack offer?

Neurotrack offers Cognitive Assessment and Cognitive Screening Platform.

Who are Neurotrack's investors?

Neurotrack has 15 investors. Key investors include Khosla Ventures, Social Capital, Johnson & Johnson Innovative Medicine, Sompo Holdings, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available